C
ONTRA
-I
NDICATIONS
Contra-Indications
* Any adhesive pad placement which applies current to
the carotid sinus (neck) region.
* Any use of TENS on a person who has a demand-type
cardiac pacemaker or defibrillator.
* Any adhesive pad placement which causes current to
flow transcerebrally (through the head).
* The use of TENS whenever pain syndromes are undiagnosed,
until etiology is established.
* Stimulation should not be applied to or in proximity to
cancerous lesions.
* Stimulation should not be applied over the neck or the
mouth. Severe spasm of the laryngeal and pharyngeal
muscles may occur and contractions may be strong enough
to close the airway or cause difficulty in breathing.
* Stimulation should not be applied transthoracically
(adhesive pads placed on the chest and upper back or
crossing over the heart).
* Any use of TENS on a person who has diagnosed neuro-
pathic pain
Warnings
* The safety of TENS devices for use during pregnancy or
birth has not been established.
* TENS is not effective for pain of central origin (this
includes headache).
* TENS devices have no curative value.
* TENS is a symptomatic treatment and as such suppresses
the sensation of pain which would otherwise serve as a
protective mechanism.
* The user must keep the device out of the reach of children.
* Electronic monitoring equipment (such as ECG monitors
and ECG alarms) may not operate properly when TENS
stimulation is in use.
* Medical opinion must be obtained before use on persons
who are insulin dependent diabetics or for persons who are
under medical supervision for any cognitive dysfunction.
* Medical opinion must be obtained before persons with any
serious illness or injury apply muscle stimulation.
* Caution should be used for muscle stimulation of pregnant
women, persons diagnosed with heart problems, persons
with cancer or diagnosed epilepsy.
* The long-term effects of chronic electrical stimulation are
unknown.
* When connecting the pads to the belt, you should insert
the metal stud completely into the connector on the belt.
* Pads and studs must not be connected to any other objects.
* Do not use the TENS device while driving or operating
machinery or during any activity where involuntary muscle
contraction may put the user at undue risk.
* Take special care when using the stimulator, as it is capable
of delivering an output of over 2mA/cm2 with some adhe-
sive pads. If in doubt, contact Bio-Medical Research Ltd.
* Simultaneous connection of a patient to high frequency
surgical equipment may result in burns at the site of the
stimulator adhesive pads, and possible damage to the
stimulator.
* Operation in close proximity to shortwave or microwave
therapy equipment may produce instability in the stimulator
output.
*
BAXOLVE
must not be used with any other unit which provides
electrical current into the body (e.g. Interferential or another
muscle stimulator).
* Use only leads and adhesive pads recommended for use
by the manufacturer.
* It may not be suitable to use
BAXOLVE
on a person at the
same time as other equipment. Check suitability before use.
* The
BAXOLVE
unit should only be used for its intended
purpose and in the same manner described in this manual.
You should also use only those pad positions indicated.
Always pause the program before adjustment, unfasten
the belt and refasten once you are comfortable.
Precautions
* Isolated cases of skin irritation may occur at the site of
adhesive pad placement following long-term application.
* Effectiveness is highly dependant upon patient selection
by a person qualified in the management of pain patients.
* Avoid applying over recent scars or on broken or inflamed
skin, areas of infection, areas susceptible to acne, throm-
bosis or other vascular problems (e.g. broken veins or
varicose veins).
* Avoid placing adhesive pads directly over metal implants
if there is not at least 1 cm of muscle fibre in between.
However, placement on the nearest muscle is possible.
If in any doubt seek medical opinion.
* Medical opinion must be obtained before applying
stimulation to parts of the body where feeling is limited
or where there is a tendency to haemorrhage following
acute trauma or fracture.
* In all cases ensure that stimulation does not exceed the
users tolerance level.
* An effective treatment should not cause undue discomfort. If
the stimulation is uncomfortable or becomes uncomfortable,
reduce the stimulation intensity to a comfortable level and
contact your physician if problems persist.
* Caution must be taken when there is a tendency to bleed
internally following an injury or fracture.
* Do not apply stimulation in the region of recent surgery,
when muscle contraction may disrupt the healing process,
without medical approval. If in any doubt seek medical
opinion.
Please do not use the
BAXOLVE
unit if:
* Positioning the adhesive pads necessitates placement over
areas at which drugs/medicines are administered by injec-
tion (short term or long term) e.g. Hormone treatment.
Adverse Reactions
* A small number of isolated skin reactions have been
reported, including allergies and acne under the pads.
* Contact Bio-Medical Research Ltd. if any irritation, skin reac-
tion, hypersensitivity or other adverse reaction is
experienced - discontinue use in the meantime.
N
OTE
:
A slight reddening of the skin is quite normal under the
adhesive pads during and for a short time after treatment.
N
OTE
:
In accordance with the laws within the member state,
safety testing on the device should be carried out every two
years.
N
OTE
:
In compliance with German law, product safety testing
must be conducted every two years by an authorised test
service.
NB: If you are in any doubt about using a
B AXO LV E
belt
for any reason, please consult your doctor before use.
A
DDITIONAL
I
NFORMATION
T
OTAL
T
REATMENT
T
IMER
If you are using
BAXOLVE
as part of a wider therapy regime, you may have to record the Total
Treatment Time for your doctor’s records. To do this, press the Program Select and Lock keys
simultaneously for 3 seconds. This will reset the total treatment time to zero. All subsequent
sessions will then be recorded and the Total Treatment Time will be displayed for 3 seconds
whenever the unit is switched on. This may be reset again when necessary.
N
OTE
:
The maximum Total Treatment Time is 99 hours and 59 minutes.
BAXOLVE
will reset back to 00:00
when this is reached.
C
ARING FOR YOUR
U
NIT
& B
ELT
Never let your
BAXOLVE
unit get wet but clean the outside regularly using a soft cloth, lightly damp-
ened in soapy water. The belt is washable, but you must first remove the unit and pads. Place the
covers on each pad until you are ready to use your
BAXOLVE
unit again. You must always follow the
instructions on the label when washing the belt.
Never machine wash your belt. Hand wash the belt in lukewarm water and NEVER wring the
belt to remove water. This protects the internal composition of the belt from damage.
Do not use any bleach when washing your belt.
Do not dry clean your belt.
Do not tumble dry your belt. You should always dry the belt on a flat surface. Do not dry the
belt over anything hot (e.g. a radiator) as it contains plastic parts. You should ensure the
belt is completely dry before use.
The belt should not be ironed.
P
AD
R
EPLACEMENT
Pads will need to be replaced from time to time and can be purchased from your
SLENDERTONE BAXOLVE
stockist or from the website www.slendertone.com.
P
RODUCT
G
UARANTEE
Should your unit develop a fault within two years of purchase,
SLENDERTONE
will undertake to replace
or repair the unit or any parts found to be defective with no charge for labour or materials *, provided
the unit:
• has been used for its intended purpose and in the manner described in this instruction manual.
• has not been connected to an unsuitable power sourc e .
• has not been subjected to misuse or neglect.
• has not been modified or repaired by anyone other than an approved
SLENDERTONE
agent.
This guarantee complements existing national guarantee obligations and does not affect your
statutory rights as a consumer.
* This excludes consumables (e.g. pads, belt etc.) when subject to normal wear and tear
12
13
E n g l i s h
Multi Baxolve IM 04/01/2006 10:27 Page 14
